Federal Register / Vol. 80, No. 27 / Tuesday, February 10, 2015 / Notices 7483 

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued 

Regulation citation Form name Number of 

respondents 

Responses 

per 

respondent 

Total 

responses 

Average burden 

per response 

(in hours) 

Total burden 

hours 

Self-Query on an Organization.427 1 427 1 427 

Continuous Query (manual).508,203 1 508,203 .08 40,656 

Continuous Query (automated).121,718 1 121,718 .0003 37 

§ 60.21: How to dispute 

the accuracy of NPDB 

information.

Subject Statement and 

Dispute.

3,501 1 3,501 .75 2,626 

Request for Dispute Resolution.94 1 94 8 752 

Administrative ................... Non-Hospital Entity Registration (Initial).524 1 524 1 524 

Non-Hospital Entity Registration (Renewal).6,383 1 6,383 .25 1,596 

Hospital Registration (Initial).37 1 37 1 37 

Hospital Registration (Renewal).3,198 1 3,198 .25 800 

Licensing Board Data Request.140 1 140 10 .5 1,470 

Reporting Entity Discrepancy Letter.389 1 389 4 1556 

Licensing Board Attestation.354 1 354 1 354 

Corrective Action Plan ...... 10 1 10 .08 1 

Reconciling Missing Actions.2,176 1 2,176 0 .8 174 

Agent Registration (Initial) 30 1 30 1 30 

Agent Registration (Renewal).194 1 194 .08 16 

Electronic Transfer of 

Funds (EFT) Authorization.

566 1 566 .08 45 

Authorized Agent Designation.788 1 788 .25 197 

Account Discrepancy ........ 41 1 41 .25 10 

Total ........................... ........................................... 5,009,324 ........................ 5,009,324 .......................... 275,689 

Jackie Painter, 

Director, Division of the Executive Secretariat. 

[FR Doc. 2015–02658 Filed 2–9–15; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Food and Drug 

Administration (FDA) and the National 

Cancer Institute (NCI) Health 

Communication Survey (FDA–NCI) 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH), has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. This proposed information 

collection was previously published in 

the Federal Register on December 4, 

2014 (Vol. 79, No. 233, pages 72003–4) 

and allowed 60 days for public 

comment. A total of five public 

comments were received. The purpose 

of this notice is to allow an additional 

30 days for public comment. The 

National Cancer Institute (NCI), 

National Institutes of Health, may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, OIRA_submission@

omb.eop.gov or by fax to 202–395–6974, 

Attention: NIH Desk Officer. 

Comment Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30-days of the date of 

this publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments or request more 

information on the proposed project 

contact: Bradford W. Hesse, Ph.D., 

Health Communication and Informatics 

Research Branch, 9609 Medical Center 

Drive, MSC 9761, Room 3E610, 

Rockville, MD 20850 or call non-toll 

free number 240–276–6721 or Email 

your request, including your address, to 

hesseb@mail.nih.gov. Formal requests 

for additional plans and instruments 

must be requested in writing. 

Proposed Collection: Health 

Information National Trends Survey 

(HINTS) 0925–0538, Reinstatement with 

Change, National Cancer Institute (NCI), 

National Institutes of Health (NIH). 


rljohnson on DSK3VPTVN1PROD with NOTICES
7484 Federal Register / Vol. 80, No. 27 / Tuesday, February 10, 2015 / Notices 

Need and Use of Information 

Collection: This partnership between 

NCI and FDA will include assessing the 

public’s knowledge of medical devices, 

communications related to product 

recalls, nutritional supplement labeling, 

and topics to inform FDA’s regulatory 

authority over tobacco, such as such as 

risk perceptions about new tobacco 

products, product pack color gradations, 

perceptions of product harm, and 

tobacco product claims and labels. This 

HINTS survey will couple knowledgerelated questions with inquiries into the 

communication channels through which 

understanding is being obtained, and 

assessment of FDA-regulated material. 

This survey will extend the information 

collected and priorities from HINTS 

which have been to provide a 

comprehensive assessment of the 

American public’s current access to, and 

use of, information about cancer across 

the cancer care continuum from cancer 

prevention, early detection, diagnosis, 

treatment, and survivorship. 

OMB approval is requested for 1 year. 

There are no costs to respondents other 

than their time. The total estimated 

annualized burden hours are 2,159. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hour 

Individuals ........................................................................................................ 4,318 1 30/60 2,159 

Dated: February 4, 2015. 

Karla Bailey, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2015–02691 Filed 2–9–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Diabetes Mellitus Interagency 

Coordinating Committee Meeting 

SUMMARY: The Diabetes Mellitus 

Interagency Coordinating Committee 

(DMICC) will hold a meeting on April 

8–9, 2015. The topic for this meeting 

will be ‘‘Opportunities for Research 

Supported by the Special Statutory 

Funding Program for Type 1 Diabetes 

Research.’’ The meeting is open to the 

public. 

DATES: The meeting will be held on 

April 8, 2015 from 8:00 a.m. to 5:45 p.m. 

and on April 9, 2015 from 8:00 a.m. to 

4:45 p.m. 

ADDRESSES: The meeting will be held at 

the NIH Neuroscience Center, 

Conference Room C (April 8) and 

Conference Room A1/A2 (April 9), 6001 

Executive Boulevard, Rockville, MD 

20852. Non-federal individuals 

planning to attend the workshop should 

register by email to Denise Hoffman, 

The Scientific Consulting Group, Inc. 

(dhoffman@scgcorp.com; please put 

‘‘Registration DMICC T1D Meeting’’ in 

the subject line) at least 7 days prior to 

the workshop. 

FOR FURTHER INFORMATION CONTACT: An 

agenda for the DMICC meeting will be 

available by contacting Denise Hoffman, 

The Scientific Consulting Group, Inc. 

(dhoffman@scgcorp.com; please put 

‘‘Agenda Request for DMICC T1D 

Meeting’’ in the subject line). For further 

information concerning this meeting, 

contact Dr. B. Tibor Roberts, Executive 

Secretary of the Diabetes Mellitus 

Interagency Coordinating Committee, 

National Institute of Diabetes and 

Digestive and Kidney Diseases, 31 

Center Drive, Building 31A, Room 

9A19, MSC 2560, Bethesda, MD 20892– 

2560, telephone: 301–496–6623; FAX: 

301–480–6741; email: dmicc@

mail.nih.gov. 

SUPPLEMENTARY INFORMATION: The 

DMICC, chaired by the National 

Institute of Diabetes and Digestive and 

Kidney Diseases (NIDDK) comprising 

members of the Department of Health 

and Human Services and other federal 

agencies that support diabetes-related 

activities, facilitates cooperation, 

communication, and collaboration on 

diabetes among government entities. 

DMICC meetings, held several times a 

year, provide an opportunity for 

Committee members to learn about and 

discuss current and future diabetes 

programs in DMICC member 

organizations and to identify 

opportunities for collaboration. The 

April 8–9, 2015 DMICC meeting will 

focus on ‘‘Opportunities for Research 

Supported by the Special Statutory 

Funding Program for Type 1 Diabetes 

Research.’’ 

Any interested person may file 

written comments with the Committee 

by forwarding their statement to the 

contact person listed on this notice. The 

statement should include the name, 

address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

Because of time constraints for the 

meeting, there will not be time on the 

agenda for oral comments from 

members of the public. 

Members of the public who would 

like to receive email notification about 

future DMICC meetings should register 

for the listserv available on the DMICC 

Web site, www.diabetescommittee.gov. 

Date: February 4, 2015. 

B. Tibor Roberts, 

Executive Secretary, DMICC, Office of 

Scientific Program and Policy Analysis, 

National Institute of Diabetes and Digestive 

and Kidney Diseases, National Institutes of 

Health. 

[FR Doc. 2015–02693 Filed 2–9–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Program 

project: Center for Integrative Biomedical 

Computing. 

Date: February 17–19, 2015. 

Time: 7:00 p.m. to 11:00 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Salt Lake City, 150 West 

500 South, Salt Lake, UT 84101. 

Contact Person: Marie-Jose Belanger, Ph.D., 

Scientific Review Officer, Center for Scentific 


rljohnson on DSK3VPTVN1PROD with NOTICES